अगला

स्वत: प्ले

MARS: mutation-adjusted risk score for advanced systemic mastocytosis

1 विचारों • 07/09/23
शेयर करना
एम्बेड
administrator
administrator
ग्राहकों
0

Andreas Reiter, MD, University Medical Centre, Mannheim, Germany, discusses how a mutation-adjusted risk score (MARS) may improve treatment stratification for advanced systemic mastocytosis (AdvSM). This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.

और दिखाओ
0 टिप्पणियाँ sort इसके अनुसार क्रमबद्ध करें
फेसबुक टिप्पणियाँ

अगला

स्वत: प्ले